Please enable JavaScript to continue using this application.

Compare $ATRA vs $OKUR | Chartloom

Compare

$ATRA vs $OKUR

Atara Biotherapeutics Inc · Onkure Therapeutics Inc

ATRA

Atara Biotherapeutics Inc

OKUR

Onkure Therapeutics Inc

Compare $ATRA vs $OKUR

Comparing Atara Biotherapeutics Inc and Onkure Therapeutics Inc

ATRAAtara Biotherapeutics Inc

OKUROnkure Therapeutics Inc

ATRAAtara Biotherapeutics Inc

Market cap

$85M

P/E (TTM)

—

Forward P/E (NTM)

14.78x

Forward P/S (NTM)

2.47x

Rev growth (TTM)

-96.7%

YTD performance

-46.7%

52W performance

-40.2%

FCF yield

-25.6%

OKUROnkure Therapeutics Inc

Market cap

$97M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

71.59x

Rev growth (TTM)

—

YTD performance

-18.6%

52W performance

-20.7%

FCF yield

-49.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ATRA

OKUR

Detailed metrics comparison

ATRA

Atara Biotherapeutics Inc

OKUR

Onkure Therapeutics Inc

Market Cap

ATRA$85M

OKUR$97M

Enterprise Value

ATRA$124M

OKUR$-69M

Price

ATRA$9.48

OKUR$2.41

P/E Ratio

ATRAN/A

OKURN/A

P/S Ratio

ATRA13.79x

OKUR0.00x

EV/Sales

ATRA19.98x

OKUR0.00x

EV/EBITDA

ATRA3.51x

OKUR0.00x

P/B Ratio

ATRA12.86x

OKUR0.60x

P/FCF Ratio

ATRAN/A

OKURN/A

EV/FCF

ATRA-5.65x

OKUR1.44x

PEG Ratio

ATRAN/A

OKURN/A

Forward P/E (NTM)

ATRA14.78x

OKURN/A

Forward P/S (NTM)

ATRA2.47x

OKUR71.59x

Revenue (TTM)

ATRA$6M

OKUR$0

Revenue Growth (YoY)

ATRA-96.7%

OKURN/A

Forward Rev Growth

ATRA1983.2%

OKUR100.0%

Gross Margin (TTM)

ATRA91.4%

OKUR0.0%

Operating Margin (TTM)

ATRA0.0%

OKUR0.0%

EBITDA Margin (TTM)

ATRA-194.7%

OKUR0.0%

Net Margin (TTM)

ATRA-269.4%

OKUR0.0%

FCF Margin (TTM)

ATRA-353.5%

OKURN/A

Net Income (TTM)

ATRA$-17M

OKUR$-59M

FCF (TTM)

ATRA$-22M

OKUR$-48M

EPS (TTM)

ATRA-$1.11

OKUR-$1.18

ROE (TTM)

ATRA-31542.0%

OKUR-4902.0%

ROA (TTM)

ATRA-7301.0%

OKUR-4577.0%

ROIC (TTM)

ATRA-30684.0%

OKUR-4902.0%

Cash

ATRA$3M

OKUR$167M

Debt

ATRA$42M

OKUR$0

Net Cash/Debt

ATRA$-38M

OKUR$167M

Current Ratio (TTM)

ATRA1.98x

OKUR26.75x

Quick Ratio (TTM)

ATRA1.98x

OKUR26.55x

Debt/Equity (TTM)

ATRA0.12x

OKUR0.00x

Debt/Assets (TTM)

ATRA0.0%

OKUR0.0%

Interest Coverage (TTM)

ATRAN/A

OKURN/A

Net Debt/EBITDA (TTM)

ATRA0.00x

OKUR0.00x

Beta

ATRA0.31

OKUR0.19

52W Performance

ATRA-40.2%

OKUR-20.7%

YTD Performance

ATRA-46.7%

OKUR-18.6%

% from 52W High

ATRA-50.5%

OKUR-55.2%

% from 52W Low

ATRA141.8%

OKUR13.1%

Asset Turnover (TTM)

ATRA0.27x

OKUR0.00x

FCF Yield (TTM)

ATRA-25.6%

OKUR-49.2%

Earnings Yield (TTM)

ATRA-19.5%

OKUR-60.3%

Dividend Yield (TTM)

ATRAN/A

OKURN/A

Rule of 40

ATRA-450.2

OKUR0.0

EV/GP/RG

ATRA0.05

OKURN/A

Ticker research

View ATRA research View OKUR research

Metric	ATRA Atara Biotherapeutics Inc	OKUR Onkure Therapeutics Inc
Market & Valuation
Market Cap	$85M	$97M
Enterprise Value	$124M	$-69M
Price	$9.48	$2.41
P/E Ratio	N/A	N/A
P/S Ratio	13.79x	0.00x
EV/Sales	19.98x	0.00x
EV/EBITDA	3.51x	0.00x
P/B Ratio	12.86x	0.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.65x	1.44x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	14.78x	N/A
Forward P/S (NTM)	2.47x	71.59x
Revenue & Growth
Revenue (TTM)	$6M	$0
Revenue Growth (YoY)	-96.7%	N/A
Forward Rev Growth	1983.2%	100.0%
Profitability
Gross Margin (TTM)	91.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-194.7%	0.0%
Net Margin (TTM)	-269.4%	0.0%
FCF Margin (TTM)	-353.5%	N/A
Net Income (TTM)	$-17M	$-59M
FCF (TTM)	$-22M	$-48M
EPS (TTM)	-$1.11	-$1.18
ROE (TTM)	-31542.0%	-4902.0%
ROA (TTM)	-7301.0%	-4577.0%
ROIC (TTM)	-30684.0%	-4902.0%
Financial Health
Cash	$3M	$167M
Debt	$42M	$0
Net Cash/Debt	$-38M	$167M
Current Ratio (TTM)	1.98x	26.75x
Quick Ratio (TTM)	1.98x	26.55x
Debt/Equity (TTM)	0.12x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.31	0.19
52W Performance	-40.2%	-20.7%
YTD Performance	-46.7%	-18.6%
% from 52W High	-50.5%	-55.2%
% from 52W Low	141.8%	13.1%
Efficiency & Yields
Asset Turnover (TTM)	0.27x	0.00x
FCF Yield (TTM)	-25.6%	-49.2%
Earnings Yield (TTM)	-19.5%	-60.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-450.2	0.0
EV/GP/RG	0.05	N/A
Ticker research	View ATRA research	View OKUR research

Valuation

P/S Ratio

OKUR

0.00x

ATRA

13.79x

EV/FCF

ATRA

-5.65x

OKUR

1.44x

Growth & revenue

Revenue Growth TTM

ATRA

-96.7%

Forward Revenue Growth

ATRA

1983.2%

OKUR

100.0%

Profitability & performance

Gross Margin

ATRA

91.4%

OKUR

0.0%

ROE

OKUR

-4902.0%

ATRA

-31542.0%

FCF Yield %

ATRA

-25.6%

OKUR

-49.2%

52-Week Performance

OKUR

-20.7%

ATRA

-40.2%

Detailed metrics comparison

ATRA

Atara Biotherapeutics Inc

OKUR

Onkure Therapeutics Inc

Market Cap

ATRA$85M

OKUR$97M

Enterprise Value

ATRA$124M

OKUR$-69M

Price

ATRA$9.48

OKUR$2.41

P/E Ratio

ATRAN/A

OKURN/A

P/S Ratio

ATRA13.79x

OKUR0.00x

EV/Sales

ATRA19.98x

OKUR0.00x

EV/EBITDA

ATRA3.51x

OKUR0.00x

P/B Ratio

ATRA12.86x

OKUR0.60x

P/FCF Ratio

ATRAN/A

OKURN/A

EV/FCF

ATRA-5.65x

OKUR1.44x

PEG Ratio

ATRAN/A

OKURN/A

Forward P/E (NTM)

ATRA14.78x

OKURN/A

Forward P/S (NTM)

ATRA2.47x

OKUR71.59x

Revenue (TTM)

ATRA$6M

OKUR$0

Revenue Growth (YoY)

ATRA-96.7%

OKURN/A

Forward Rev Growth

ATRA1983.2%

OKUR100.0%

Gross Margin (TTM)

ATRA91.4%

OKUR0.0%

Operating Margin (TTM)

ATRA0.0%

OKUR0.0%

EBITDA Margin (TTM)

ATRA-194.7%

OKUR0.0%

Net Margin (TTM)

ATRA-269.4%

OKUR0.0%

FCF Margin (TTM)

ATRA-353.5%

OKURN/A

Net Income (TTM)

ATRA$-17M

OKUR$-59M

FCF (TTM)

ATRA$-22M

OKUR$-48M

EPS (TTM)

ATRA-$1.11

OKUR-$1.18

ROE (TTM)

ATRA-31542.0%

OKUR-4902.0%

ROA (TTM)

ATRA-7301.0%

OKUR-4577.0%

ROIC (TTM)

ATRA-30684.0%

OKUR-4902.0%

Cash

ATRA$3M

OKUR$167M

Debt

ATRA$42M

OKUR$0

Net Cash/Debt

ATRA$-38M

OKUR$167M

Current Ratio (TTM)

ATRA1.98x

OKUR26.75x

Quick Ratio (TTM)

ATRA1.98x

OKUR26.55x

Debt/Equity (TTM)

ATRA0.12x

OKUR0.00x

Debt/Assets (TTM)

ATRA0.0%

OKUR0.0%

Interest Coverage (TTM)

ATRAN/A

OKURN/A

Net Debt/EBITDA (TTM)

ATRA0.00x

OKUR0.00x

Beta

ATRA0.31

OKUR0.19

52W Performance

ATRA-40.2%

OKUR-20.7%

YTD Performance

ATRA-46.7%

OKUR-18.6%

% from 52W High

ATRA-50.5%

OKUR-55.2%

% from 52W Low

ATRA141.8%

OKUR13.1%

Asset Turnover (TTM)

ATRA0.27x

OKUR0.00x

FCF Yield (TTM)

ATRA-25.6%

OKUR-49.2%

Earnings Yield (TTM)

ATRA-19.5%

OKUR-60.3%

Dividend Yield (TTM)

ATRAN/A

OKURN/A

Rule of 40

ATRA-450.2

OKUR0.0

EV/GP/RG

ATRA0.05

OKURN/A

Ticker research

View ATRA research View OKUR research

Metric	ATRA Atara Biotherapeutics Inc	OKUR Onkure Therapeutics Inc
Market & Valuation
Market Cap	$85M	$97M
Enterprise Value	$124M	$-69M
Price	$9.48	$2.41
P/E Ratio	N/A	N/A
P/S Ratio	13.79x	0.00x
EV/Sales	19.98x	0.00x
EV/EBITDA	3.51x	0.00x
P/B Ratio	12.86x	0.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.65x	1.44x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	14.78x	N/A
Forward P/S (NTM)	2.47x	71.59x
Revenue & Growth
Revenue (TTM)	$6M	$0
Revenue Growth (YoY)	-96.7%	N/A
Forward Rev Growth	1983.2%	100.0%
Profitability
Gross Margin (TTM)	91.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-194.7%	0.0%
Net Margin (TTM)	-269.4%	0.0%
FCF Margin (TTM)	-353.5%	N/A
Net Income (TTM)	$-17M	$-59M
FCF (TTM)	$-22M	$-48M
EPS (TTM)	-$1.11	-$1.18
ROE (TTM)	-31542.0%	-4902.0%
ROA (TTM)	-7301.0%	-4577.0%
ROIC (TTM)	-30684.0%	-4902.0%
Financial Health
Cash	$3M	$167M
Debt	$42M	$0
Net Cash/Debt	$-38M	$167M
Current Ratio (TTM)	1.98x	26.75x
Quick Ratio (TTM)	1.98x	26.55x
Debt/Equity (TTM)	0.12x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.31	0.19
52W Performance	-40.2%	-20.7%
YTD Performance	-46.7%	-18.6%
% from 52W High	-50.5%	-55.2%
% from 52W Low	141.8%	13.1%
Efficiency & Yields
Asset Turnover (TTM)	0.27x	0.00x
FCF Yield (TTM)	-25.6%	-49.2%
Earnings Yield (TTM)	-19.5%	-60.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-450.2	0.0
EV/GP/RG	0.05	N/A
Ticker research	View ATRA research	View OKUR research